Hernan Garcia-Ruiz | Virology | Best Researcher Award

Published on by Environmental Scientists

Dr. Hernan Garcia-Ruiz | Virology | Best Researcher Award

Associate Professor | University of Nebraska-Lincoln | United States

Dr. Hernan Garcia-Ruiz is an accomplished Associate Professor of Virology recognized for his impactful research on virus host interactions and antiviral immunity in plants. His scientific contributions address one of the most pressing challenges in agriculture viral diseases that threaten global food security. Dr. Hernan Garcia-Ruiz research explores the molecular mechanisms by which plants defend themselves against viral pathogens, focusing on RNA silencing pathways, viral genome variation, and genetic determinants of resistance. His studies have provided fundamental insights into how viral and host genomes coevolve, laying the groundwork for innovative approaches to design artificial antiviral immunity in crops where natural resistance is lacking. His work not only deepens the understanding of plant molecular virology but also contributes to the development of sustainable agricultural solutions aimed at reducing socioeconomic disruptions caused by viral outbreaks. A recipient of multiple prestigious honors including recognition among the top 2% of scientists globally by Stanford/Elsevier Dr. Hernan Garcia-Ruiz scholarship has been consistently acknowledged for its excellence and real-world relevance. He has also received the Helen Hay Whitney Postdoctoral Fellowship and the Riker Award for outstanding research and teaching achievements. Beyond research, Dr. Hernan Garcia-Ruiz is deeply committed to education, mentoring the next generation of plant pathologists and virologists through advanced coursework in molecular and plant virology. His pioneering vision continues to bridge molecular biology, genomics, and biotechnology to enhance the resilience of crops and ensure global food sustainability. He has 2,131 citations by 1,789 documents, 32 published works, and an h-index of 18.

Profiles: Scopus | Orcid | Google Scholar | LinkedIn

Featured Publications

Garcia-Ruiz, H., Takeda, A., Chapman, E. J., Sullivan, C. M., Fahlgren, N., et al. (2010). Arabidopsis RNA-dependent RNA polymerases and dicer-like proteins in antiviral defense and small interfering RNA biogenesis during Turnip Mosaic Virus infection. The Plant Cell, 22(2), 481–496.

Cuperus, J. T., Carbonell, A., Fahlgren, N., Garcia-Ruiz, H., Burke, R. T., Takeda, A., et al. (2010). Unique functionality of 22-nt miRNAs in triggering RDR6-dependent siRNA biogenesis from target transcripts in Arabidopsis. Nature Structural & Molecular Biology, 17(8), 997–1003.

Carbonell, A., Fahlgren, N., Garcia-Ruiz, H., Gilbert, K. B., Montgomery, T. A., et al. (2012). Functional analysis of three Arabidopsis ARGONAUTES using slicer-defective mutants. The Plant Cell, 24(9), 3613–3629.

El-Mounadi, K., Morales-Floriano, M. L., & Garcia-Ruiz, H. (2020). Principles, applications, and biosafety of plant genome editing using CRISPR-Cas9. Frontiers in Plant Science, 11, 56.

Garcia-Ruiz, H., Carbonell, A., Hoyer, J. S., Fahlgren, N., Gilbert, K. B., Takeda, A., et al. (2015). Roles and programming of Arabidopsis ARGONAUTE proteins during Turnip Mosaic Virus infection. PLoS Pathogens, 11(3), e1004755.*

PANAGIOTA TSIATSIOU | Virology | Best Researcher Award

Published on by Environmental Scientists

Dr. PANAGIOTA TSIATSIOU | Virology | Best Researcher Award

Director of the Hematology Laboratory, AHEPA University Hospital, Greece

Dr. Panagiota Tsiatsiou is a distinguished medical biopathologist with over two decades of extensive experience in clinical microbiology and hematology diagnostics. She currently serves as the Director of the Hematology Section at AHEPA University Hospital in Thessaloniki, Greece. Renowned for her dedication to precision medicine, she has played a pivotal role in modernizing hematological laboratory protocols, especially during the COVID-19 pandemic. Her expertise spans molecular diagnostics, hemoglobinopathies, and hemostasis, and she actively mentors future medical biopathologists through structured clinical training programs. 🏥🧬📊

Professional Profile

Scopus

Orcid

🎓 Education

Dr. Tsiatsiou received her M.D. from the School of Health Sciences at Aristotle University of Thessaloniki (1988–1995). She completed her rural medical service in Evros (1996–1997) and specialized in Medical Biopathology at Theageneio Anticancer Hospital of Thessaloniki (1997–2002), earning board certification in 2002. 📚👩‍🔬 She holds three master’s degrees: in Health Services Management (Hellenic Open University), Public Health (National School of Public Health), and Biomedical Sciences in Diagnosis and Therapy (Democritus University of Thrace & IHU), each supported by robust thesis research on blood donor psychology, foodborne infections, and FV Leiden mutations respectively. 📖🔍🧪

💼 Experience

From 2003 to 2020, Dr. Tsiatsiou held various laboratory positions within Greece’s National Health System, contributing to critical microbiological investigations. Since 2011, she has worked at AHEPA University Hospital, where she was appointed Director of the Hematology Section in 2018. 🏥💉 Her primary responsibilities include the diagnostic evaluation of hemoglobinopathies, coagulation disorders, and molecular hematology. She also oversees training programs for medical residents and was instrumental in managing laboratory diagnostics for COVID-19 hemostasis complications. 🔬🦠📈

🔬 Research Interests

Her research interests lie in hematological molecular diagnostics, hemoglobinopathy prevalence, and biomarkers in infectious diseases, particularly in the context of COVID-19. She is deeply involved in translational research, focusing on the role of angiopoietins and genetic mutations such as FV Leiden in disease prognosis and diagnostics. 🧬🩸📊 Her work aims to bridge clinical application and molecular understanding, particularly in the domains of public health risk profiling and diagnostic accuracy.

🏆 Awards

While specific awards were not enumerated, Dr. Tsiatsiou’s sustained leadership, scientific output, and her appointment as Director of a major hematology unit underscore her professional excellence. 🏆📜 Her postgraduate honors and impactful roles during the COVID-19 crisis speak to a career rooted in public service, scientific integrity, and innovation in diagnostic science. 🌟🔖👩‍⚕️

📚 Top Noted Publications

Tsiatsiou, P. (2024). Angiopoietins as Predictor Indexes in COVID-19 Patients in Delta and Omicron Waves, Current Issues in Molecular Biology.
🔗 Read the Article – Published in 2024, Current Issues in Molecular Biology – Cited in ongoing research evaluating COVID-19 biomarkers.

Conclusion

Dr. Panagiota Tsiatsiou is a highly suitable candidate for the Best Researcher Award, particularly in fields of Medical Biopathology, Hematology Diagnostics, and Public Health Research. Her academic rigor, clinical leadership, and contributions to health systems resilience during the COVID-19 pandemic distinguish her as a multidisciplinary expert and public health advocate. With further emphasis on international collaboration and high-impact publishing, her research legacy will continue to grow. She is both a deserving nominee and a role model for future medical scientists. 🌟🔬🥇

Hazrat Bilal | Microbiology | Best Researcher Award

Published on by Environmental Scientists

Assoc. Prof. Dr. Hazrat Bilal | Microbiology | Best Researcher Award

Associate professor, Jiangxi Key Laboratory of oncology, JXHC Key Laboratory of Tumor Metastasis, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Cancer Institute, Nanchang, Jiangxi, 330029, P.R. China, China🧬

Dr. Hazrat Bilal is a distinguished microbiologist specializing in infectious diseases and antimicrobial resistance. With a strong academic foundation and extensive research experience, he has contributed significantly to the understanding of fungal infections and antibiotic resistance. He has received multiple accolades for his academic excellence and research contributions, including gold medals during his M.Phil. and BS studies. Currently, he is serving as a researcher at Jiangxi Cancer Hospital, China, and has held various positions in both academia and the pharmaceutical industry. His groundbreaking work in microbiology has been published in high-impact journals, making valuable contributions to the scientific community.

Profile

Google Scholar

Education 🎓

Dr. Hazrat Bilal has a strong academic background in microbiology, earning prestigious degrees with honors. He obtained his Ph.D. in Ecology (Microbiology specialization) from Anhui University, China (2018–2021). Before that, he completed his M.Phil. in Microbiology from Khyber Medical University, Pakistan (2016–2018), graduating as a Gold Medalist with the highest CGPA of 3.85/4. His BS (Hons) in Microbiology was awarded by Hazara University, Pakistan (2010–2014), where he again graduated with the highest distinction and a CGPA of 3.92/4, securing another Gold Medal for academic excellence.

Professional Experience 🔬

Dr. Bilal is currently working as a researcher at Jiangxi Cancer Hospital, China (March 2024 – Present). Previously, he served as a Postdoctoral Researcher at the Second Affiliated Hospital of SUMC, Shantou, China (March 2022 – March 2024), where he conducted extensive research on infectious diseases. Before transitioning into research, he worked as a Medicinal Sales Officer at Sami Pharmaceutical Company Pvt Ltd, Pakistan (December 2014 – February 2016), gaining industry experience in pharmaceutical sales and drug distribution.

Research Interests 🦠

Dr. Bilal’s research primarily focuses on microbiology, infectious diseases, and antimicrobial resistance. His work includes epidemiological studies, fungal infections, antifungal drug susceptibility, and molecular mechanisms of antibiotic resistance. He has extensively studied Candida and Aspergillus infections, drug resistance patterns, and microbial dysbiosis, contributing significantly to the field of medical microbiology.

Awards & Honors 🏆

Dr. Bilal has received multiple accolades throughout his academic and professional career. He was a Gold Medalist in both his BS (Hons) and M.Phil. degrees, recognizing his outstanding academic performance. Additionally, his research has been recognized internationally, with publications in high-impact journals. His work continues to be cited widely, solidifying his reputation in the field of microbiology and infectious disease research.

Publications 📚

Epidemiology and antifungal susceptibilities of clinically isolated Aspergillus species in South China
Epidemiology and Infection (IF: 4.2, Q2), 2023 | Cited by: Google Scholar

Risk of candidiasis associated with interleukin-17 inhibitors: implications and management
Mycology: An International Journal of Fungal Biology (IF: 4.2, Q1), 2023 | Cited by: Google Scholar

Cryptococcosis in Southern China: Insights from a Six-Year Retrospective Study
Infection and Drug Resistance (IF: 3.9, Q2), 2023 | Cited by: Google Scholar

Six-Year Retrospective Analysis of Epidemiology, Risk Factors, and Antifungal Susceptibilities of Candidiasis
Microbiology Spectrum (IF: 9.043, Q1), 2023 | Cited by: Google Scholar

Stabilization of Acne Vulgaris-Associated Microbial Dysbiosis with 2% Supramolecular Salicylic Acid
Pharmaceuticals (IF: 5.215, Q1), 2023 | Cited by: Google Scholar

Distribution and antifungal susceptibility pattern of Candida species from mainland China
Virulence (IF: 5.428, Q2), 2022 | Cited by: Google Scholar

Antifungal susceptibility pattern of Candida isolated from cutaneous candidiasis patients in Eastern Guangdong
Frontiers in Microbiology (IF: 6.064, Q1), 2022 | Cited by: Google Scholar

First Report of blaNDM-1 Bearing IncX3 Plasmid in Clinically Isolated ST11 Klebsiella pneumoniae from Pakistan
Microorganisms (IF: 4.926, Q2), 2021 | Cited by: Google Scholar

Molecular Epidemiology of mcr-1, blaKPC-2, and blaNDM-1 Harboring Clinically Isolated Escherichia coli from Pakistan
Infection and Drug Resistance (IF: 4.177, Q2), 2021 | Cited by: Google Scholar

Antibiotic resistance in Pakistan: A systematic review of the past decade
BMC Infectious Diseases (IF: 3.669, Q3), 2021 | Cited by: Google Scholar

Conclusion

Dr. Bilal H. is a highly competent researcher with a strong track record in microbiology, infectious diseases, and antimicrobial resistance. His extensive publication record, international research exposure, and academic excellence make him a strong contender for the Best Researcher Award. Further development in leadership, funding acquisition, and industry collaborations would further solidify his standing in the field. 🌟